Alcobra Ltd. To Participate In Upcoming Healthcare Conferences

TEL AVIV, Israel, Nov. 07, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that management will participate in several upcoming investor healthcare conferences.
Stifel Healthcare Conference
Date: Tuesday, November 15
Time: 4:30PM EST
Location: The Lotte New York Palace Hotel
   
Jefferies London Healthcare Conference
Date: Thursday, November 17
Time: 09:20AM GMT
Location: Waldorf Hilton, London, United Kingdom
Webcast: http://wsw.com/webcast/jeff100/adhd
   
28 th Annual Piper Jaffray Healthcare Conference
Date: Tuesday, November 29
Time: 10:00AM EST
Panel Title:     Underdiscovered Neuro-Innovators Panel
Location: The Lotte New York Palace Hotel
   
Oppenheimer Life Sciences Summit
Date: Tuesday, November 29
Location: The Sofitel New York Hotel
   

If you liked this article you might like

Alcobra Shares Plummet as ADHD Drug Fails

Corbus Pharma Bear Thesis Is Alive and Well on Sclerosis Drug Data Skewed Positive

Alcobra (ADHD) Stock Sliding, Downgraded After FDA Clinical Hold

Alcobra (ADHD) Stock Tumbles on FDA Clinical Hold, Cantor Remains Bullish

7 Stocks Under $10 Making Big Moves Higher